State Street’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
ACM
TGA
PBPIA
NCM
AC
RC
State Street's RLYB Position: Q2 2026 in Review
State Street opened a new position in Rallybio (RLYB) in Q2 2026: 12,996 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #3823 among its holdings. This is a return to the name: State Street previously reported a position in RLYB as recently as Q4 2025.
State Street first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.65M in Q3 2022. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.
- State Street held 12,996 shares of Rallybio worth $208K as of Q2 2026.
- Rallybio was a new State Street position in Q2 2026.
- Rallybio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3823 holding.
- State Street first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
- State Street's Rallybio position peaked at $3.65M in Q3 2022.
- 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.